Financhill
Buy
63

GIFLF Quote, Financials, Valuation and Earnings

Last price:
$12.90
Seasonality move :
-8.35%
Day range:
$12.90 - $12.90
52-week range:
$8.50 - $14.00
Dividend yield:
1.35%
P/E ratio:
19.14x
P/S ratio:
1.03x
P/B ratio:
1.42x
Volume:
--
Avg. volume:
747
1-year change:
35.36%
Market cap:
$8.8B
Revenue:
$8.5B
EPS (TTM):
$0.67

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Grifols SA has -- downside to fair value with a price target of -- per share.

GIFLF vs. S&P 500

  • Over the past 5 trading days, Grifols SA has underperformed the S&P 500 by -3.25% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Grifols SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Grifols SA has grown year-over-year revenues for 13 quarters straight. In the most recent quarter Grifols SA reported revenues of $2.3B.

Earnings Growth

  • Grifols SA has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Grifols SA reported earnings per share of $0.17.
Enterprise value:
20.8B
EV / Invested capital:
--
Price / LTM sales:
1.03x
EV / EBIT:
14.71x
EV / Revenue:
2.45x
PEG ratio (5yr expected):
0.11x
EV / Free cash flow:
28.66x
Price / Operating cash flow:
12.08x
Enterprise value / EBITDA:
10.89x
Gross Profit (TTM):
$3.2B
Return On Assets:
2.48%
Net Income Margin (TTM):
6.68%
Return On Equity:
6.37%
Return On Invested Capital:
2.93%
Operating Margin:
13.87%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $7.1B $7.8B $8.5B $2.1B $2.3B
Gross Profit $2.7B $3B $3.2B $817.6M $799.4M
Operating Income $909.4M $1.2B $1.4B $407.5M $319.9M
EBITDA $1.4B $1.7B $1.9B $525M $469.3M
Diluted EPS $0.22 $0.25 $0.67 $0.11 $0.17
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets -- $5B $6.8B $5.9B $6B
Total Assets -- $22.8B $23.2B $22.2B $23.2B
Current Liabilities -- $2.2B $2.6B $2.2B $2.4B
Total Liabilities -- $14.2B $14.9B $13.3B $14.3B
Total Equity -- $8.6B $8.3B $8.9B $8.9B
Total Debt -- -- $10.5B $9.3B $10.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations -- $962.3M $1.2B $536.6M $498.6M
Cash From Investing -- $945.8M -$673.9M -$224.1M -$174.1M
Cash From Financing -- -$1.4B -$615.7M $13.4M -$85.4M
Free Cash Flow -- $566.2M $726.3M $391.6M $343.8M
GIFLF
Sector
Market Cap
$8.8B
$23.9M
Price % of 52-Week High
92.14%
47.44%
Dividend Yield
1.35%
0%
Shareholder Yield
5.22%
-1.88%
1-Year Price Total Return
35.36%
-18.29%
Beta (5-Year)
0.846
0.513
Dividend yield:
1.35%
Annualized payout:
$0.17
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $12.90
200-day SMA
Buy
Level $12.74
Bollinger Bands (100)
Buy
Level 11.48 - 13.06
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $12.90
Relative Strength Index (RSI14)
Buy
Level 98.07
ADX Line
Neutral
Level
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $12.38
MACD (12, 26)
Buy
Level 2.87
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.0838)
Sell
CA Score (Annual)
Level (-1.0945)
Buy
Beneish M-Score (Annual)
Level (-2.5019)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.6507)
Buy
Piotroski F Score (Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

Stock Forecast FAQ

In the current month, GIFLF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GIFLF average analyst price target in the past 3 months is --.

  • Where Will Grifols SA Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Grifols SA share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Grifols SA?

    Analysts are divided on their view about Grifols SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Grifols SA is a Sell and believe this share price will rise from its current level to --.

  • What Is Grifols SA's Price Target?

    The price target for Grifols SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is GIFLF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Grifols SA is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of GIFLF?

    You can purchase shares of Grifols SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Grifols SA shares.

  • What Is The Grifols SA Share Price Today?

    Grifols SA was last trading at $12.90 per share. This represents the most recent stock quote for Grifols SA. Yesterday, Grifols SA closed at $12.90 per share.

  • How To Buy Grifols SA Stock Online?

    In order to purchase Grifols SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
46
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 27x

Alerts

Buy
51
AAOI alert for Apr 3

Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.

Buy
59
SBAC alert for Apr 3

SBA Communications Corp. [SBAC] is up 18.96% over the past day.

Buy
55
VSAT alert for Apr 3

ViaSat, Inc. [VSAT] is up 18.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock